Otros idiomas RaQualia Pharma Inc.

Acciones

4579

JP3967150008

Diferido Japan Exchange Otros sitios de cotización 03:58:03 22/05/2024			Varia. Cinco días.	Varia. 1 de enero.
568 ^JPY	-0,18 %		-2,40 %	-17,30 %

26/03	RaQualia Pharma Inc. (TSE:4579) completó la adquisición de FIMECS, Inc. a Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership gestionada por Nissay Capital Co., Ltd., ANRI No. 4 Fund gestionada por ANRI y otros.	CI
14/02	RaQualia Pharma Inc. proporciona una previsión de beneficios consolidados para el año que finaliza el 31 de diciembre de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	26/03
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	14/02
RaQualia Pharma Inc. agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion.	14/02
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	10/08/23
Constipation Pipeline, Clinical Trials, and Key Companies\|Companies-Anji Pharma, Yuhan, Theravance Biopharma	12/06/23
RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	15/05/23
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	14/02/23
RaQualia Pharma Inc. announced that it has received ¥805.6125 million in funding from CVI Investments, Inc.	05/01/23
RaQualia Pharma Inc. announced that it expects to receive Ã‘805.6125 million in funding from CVI Investments, Inc.	20/12/22
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for Year Ending December 31, 2022	11/11/22
RaQualia Pharma : Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (JGAAP)	15/08/22
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	15/08/22
RaQualia Pharma : (Delayed)Summary of Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (JGAAP)	15/02/22
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	15/02/22
RaQualia Pharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12/11/21
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2021	12/08/21
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Six Months Ended June 30, 2021	12/08/21
RaQualia Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2021	14/05/21
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	14/05/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas RaQualia Pharma Inc.

Acciones

4579

JP3967150008

Otros idiomas

Filtros